Be the solution

Accelerate COVID-19 research.
Your contribution to the UNC COVID-19 Research Accelerator Fund provides immediate, flexible support to Carolina's critical research teams focused on COVID-19 testing, treatment and prevention. Be the solution. Help provide our researchers with the resources needed most to mitigate this pandemic and prepare us for the next.

Researcher wearing gloves to pour liquid in test tube
Fill the gaps.

Right now, while many of us are doing our part to mitigate the spread of COVID-19, UNC-Chapel Hill’s researchers, experts, scientists and staff are fervently working to find solutions so that we can save lives, reduce suffering, and safely reopen our state, our nation and our world. Vital resources are needed now to fill the gaps in existing and evolving research opportunities for Carolina to better execute its rapid response to this global pandemic.

The breadth and depth of Carolina’s COVID-19 research is astounding but not surprising: UNC-Chapel Hill has been a leader in pandemic research for decades, from pioneering treatments for infectious diseases like HIV/AIDS to leading novel testing and development of antiviral therapies and vaccines for emerging threats like Ebola, Zika and coronavirus. Now, Carolina is tackling the COVID-19 crisis head-on through our expertise in microbiology, immunology, epidemiology, pharmacology, on-campus specialized clinical care for lungs and all other systems of the human body.

UNC Research: Tackling COVID-19

From the labs to in the community, UNC celebrates the tireless efforts and ongoing work of the Carolina COVID-19 researchers and responders in this short video documenting their wide-ranging work.

Eliminate roadblocks.

Housed in UNC’s Office of the Vice Chancellor for Research that oversees, develops and supports Carolina’s $1.1 billion research enterprise, the UNC COVID-19 Research Accelerator Fund provides critical unrestricted support to Carolina’s world-renowned research teams — eliminating roadblocks and cutting through barriers to deliver the resources needed most to mitigate this pandemic and prepare us for the next.

Our research teams encounter a wide range of needs, from highly specialized equipment to supplies, services and data, to hiring invaluable postdoctoral researchers and specialists to help coordinate activities between labs.

Accelerate. Advance. Act.

Your contributions to the UNC COVID-19 Research Accelerator Fund will be quickly dispersed where most needed to accelerate existing research capacity and advance new projects. You can make an immediate impact. For questions about the fund or specific areas of research, contact Mark Meares at [email protected].

Uniquely positioned to find solutions.
  • Recently, Reuters named UNC-Chapel Hill the sixth most innovative university in the world.
  • Carolina received more than $1 billion in sponsored research in fiscal year 2020.
  • UNC-Chapel Hill is home to five U.S. News & World Report top-ranked health sciences schools, including our schools of pharmacy, public health, medicine, nursing and dentistry.

Carolina has 4 health sciences schools with top-10-ranked graduate programs, including UNC Eshelman School of Pharmacy, UNC Gillings School of Global Public Health, UNC School of Medicine, and UNC School of Nursing. Carolina is also rated the #6 most innovative university in the world.

Carolina's Frontline
COVID-19 Research

UNC-Chapel Hill faculty researchers, scientists and staff are working collaboratively with teams on campus and partners around the world on COVID-19 research projects in five key areas: Testing/Diagnostics, Treatment, Prevention/Preparation, Clinical Care Research, and Outcomes and Impact Research.

Learn more Opens in new window

COVID-19 Research Highlights
at UNC-Chapel Hill

Rachel Noble

Testing Water Systems for COVID-19

UNC-Chapel Hill researcher Rachel Noble is studying the transmissibility of COVID-19 through water and the environment.


Coronavirus drug shows promise at Carolina

Potential relief to the coronavirus pandemic.


COVID-19 testing at UNC Medical Center

On Monday, March 16, Dr. Melissa Miller and her team began testing patients for COVID-19 at UNC Medical Center.


Monitoring Disease through Social Media

Can social media help track the spread of disease?


READDI for the Future

“READDI has the potential to make sure we are never caught off-guard again.”

Jessica Lin

Addressing the COVID-19 infection rate of household members

A study led by Jessica Lin, an infectious disease researcher at UNC, is addressing the COVID-19 infection rate of household members.

    Support Carolina's
    Critical Research

    Act now. Give to the UNC COVID-19 Research Accelerator Fund today.

    Make a gift to the UNC COVID-19 Research Accelerator Fund Opens in new window